This Article Full Text Full Text (PDF) All Versions of this Article: 21/12/2988    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Google Scholar Articles by Velarde, M. C. Articles by Simmen, R. C. M. PubMed PubMed Citation Articles by Velarde, M. C. Articles by Simmen, R. C. M.

Krüppel-Like Factor 9 Is a Negative Regulator of Ligand-Dependent Estrogen Receptor Signaling in Ishikawa Endometrial Adenocarcinoma Cells

Department of Physiology and Biophysics, University of Arkansas for Medical Sciences and Arkansas Children’s Nutrition Center, Little Rock, Arkansas 72202

Address all correspondence and requests for reprints to: Rosalia C.M. Simmen, Ph.D., Department of Physiology and Biophysics, University of Arkansas for Medical Sciences and Arkansas Children’s Nutrition Center, 1120 Marshall Street, Little Rock, Arkansas 72202. E-mail: simmenrosalia{at}uams.edu.

Estrogen and progesterone, acting through their respective receptors and other nuclear proteins, exhibit opposing activities in target cells. We previously reported that Krüppel-like factor 9 (KLF9) cooperates with progesterone receptor (PR) to facilitate P-dependent gene transcription in uterine epithelial cells. Here we evaluated whether KLF9 may further support PR function by directly opposing estrogen receptor (ER) signaling. Using human Ishikawa endometrial epithelial cells, we showed that 17β-estradiol (E₂)-dependent down-regulation of ER expression was reversed by a small interfering RNA to KLF9. Transcription assays with the E₂-sensitive 4x estrogen-responsive element-thymidine kinase-promoter-luciferase reporter gene demonstrated inhibition of ligand-dependent ER transactivation with ectopic KLF9 expression. E₂ induced PR-A/B and PR-B isoform expression in the absence of effects on KLF9 levels. Addition of KLF9 small interfering RNA augmented E₂ induction of PR-A/B while abrogating that of PR-B, indicating selective E₂-mediated inhibition of PR-A by KLF9. Chromatin immunoprecipitation of the ER minimal promoter demonstrated KLF9 promotion of E₂-dependent ER association to a region containing functional GC-rich motifs. KLF9 inhibited the recruitment of the ER coactivator specificity protein 1 (Sp1) to the PR proximal promoter region containing a half-estrogen responsive element and GC-rich sites, but had no effect on Sp1 association to the PR distal promoter region containing GC-rich sequences. In vivo association of KLF9 and Sp1, but not of ER with KLF9 or Sp1, was observed in control and E₂-treated cells. Our data identify KLF9 as a transcriptional repressor of ER signaling and suggest that it may function at the node of PR and ER genomic pathways to influence cell proliferation.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  PR

Ligands:   17β-Estradiol  |  Fulvestrant